J Biol Chem, Vol. 275, Issue 3, 1665-1672, January 21, 2000
The Spectral and Thermodynamic Properties of Staphylococcal
Enterotoxin A, E, and Variants Suggest That Structural Modifications
Are Important to Control Their Function*
Anders
Cavallin
,
Helena
Arozenius
,
Karin
Kristensson
,
Per
Antonsson
,
Daniel E.
Otzen§,
Per
Björk
, and
Göran
Forsberg
¶
From the
Active Biotech Research AB, Box 724, 22007 Lund, Sweden and the § Department of Biochemistry,
Center for Chemistry and Chemical Engineering, Lund University, P. O. Box 124, S-22100 Lund, Sweden
 |
ABSTRACT |
The superantigens staphylococcal enterotoxin A
and E (SEA and SEE) can activate a large number of T-cells. SEA and SEE
have approximately 80% sequence identity but show some differences in
their biological function. Here, the two superantigens and analogues
were characterized biophysically. SEE was shown to have a substantially
higher thermal stability than SEA. Both SEA and SEE were thermally
stabilized by 0.1 mM Zn2+ compared with
Zn2+-reduced conditions achieved using 1 mM
EDTA or specific replacements that affect Zn2+
coordination. The higher stability of SEE was only partly caused by the
T-cell receptor (TCR) binding regions, whereas regions in the vicinity
of the major histocompatibility complex class II binding sites affected
the stability to a greater extent. SEE exhibited a biphasic
denaturation between pH 5.0-6.5, influenced by residues in the TCR
binding regions. Interestingly, enzyme-linked immunosorbent assay,
isoelectric focusing, and circular dichroism analysis indicated that
conformational changes had occurred in the SEA/E chimerical constructs
relative to SEA and SEE. Thus, it is proposed that the Zn2+
binding site is very important for the stability and potency of SEA and
SEE, whereas residues in the TCR binding site have a substantial
influence on the molecular conformation to control specificity and function.
 |
INTRODUCTION |
Superantigens (SAgs)1
such as the staphylococcal enterotoxins (SE) are very potent
T-cell-activating proteins known to cause food poisoning or toxic shock
(1). SEs bind as unprocessed proteins to MHC class II molecules and
activate T-cells displaying certain V
regions of T-cell receptor
(TCR) (2, 3). Because the number of V
-genes is limited, a much
larger fraction of the T-cells is activated by SAgs than by normal
antigens (2, 4). The strong cytotoxicity induced by these enterotoxins
has been explored for cancer therapy by fusing them to tumor-reactive
antibodies (5, 6).
Nine different SEs have been identified and these are designated
SEA-SEE and SEG-SEJ. The sequence identity of these SAgs with SEA
ranges from 20% for SEG to 82% for SEE (described in greater detail
in Refs. 7 and 8). The binding to MHC class II of both SEA and SEE is
known to be Zn2+-dependent (9). Both SEA and
SEE have two MHC class II binding sites, one close to the N terminus
with low affinity for MHC class II and one close to the C terminus with
moderate affinity. These two sites may cooperate and cross-link MHC
class II molecules with a higher affinity (10, 11). In addition the
ability to cross-link two neighboring MHC class II molecules may
stimulate secretion of inflammatory cytokines, such as interleukin-6,
interleukin-8 (12), and interleukin-1
(13). One of these
interactions is stabilized by a Zn2+ ion, coordinated by
His187, His225, and Asp227 in SEA (14) and His81 in the MHC class II
-chain (15). Replacing any of the residues Asp-227, His-225, and
His-187 with Ala dramatically decreases the affinity for
Zn2+ and subsequently MHC class II (10). SEA and SEE behave
similarly in many functional assays, for example human T-cell
proliferation and MHC class II-dependent cytotoxicity
assays (16). However, the V
specificity (2, 16, 17) differs slightly
between SEA and SEE, and in contrast to SEE, SEA can induce a strong
MHC class II-independent T-cell response. This indicates that
presentation on MHC class II is more important for optimal activation
of T-cells with SEE (16). As a consequence, these intrinsic differences in the TCR binding sites of SEA and SEE indicate that the affinity of
SEA for the TCR may be different compared with SEE.
In this study, the differences in stability between SEA and SEE were
studied and compared with functional data. To address differences on
the molecular level, engineered chimeras as well as variants with
specific replacements were investigated. Exchanging parts of the SEA
amino acid sequence for the corresponding sequence from SEE or vice
versa induces conformational changes in the tertiary structure that
could be important for the T-cell-activating properties. Also, the
influence of the Zn2+ binding site, which is important for
MHC class II binding, on the structural stability of the SAgs was investigated.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Horseradish peroxidase-labeled goat anti-human
IgG (
-specific), Sigma FastTM OPD peroxidase substrate tablets, and
L-methionine sulfoximine were purchased from Sigma.
Purified IgG pool was from Pharmacia & Upjohn AB (Stockholm, Sweden).
Dry milk (fat-free) was from Semper AB (Stockholm, Sweden) and
horseradish peroxidase-labeled rabbit anti-SEA antibodies were from
Toxin Technology (Sarasota, FL).
Na251CrO4 was from Amersham
Pharmacia Biotech. The restriction enzymes BglII and
HindIII were from Roche Molecular Biochemicals and Life Technologies, Inc., respectively, and T4 ligase was from Roche Molecular Biochemicals.
RPMI 1640 cell growth medium and HEPES were from Bio Whittaker
(Verviers, Belgium) and Hank's balanced salt solution without phenol
red was from Life Technologies, Inc. R10 fetal bovine calf serum was
from Hy-Clone Laboratories Inc. (Logan, UT). Gentamycin sulfate was
from Biological Industries (Kibbutz Beit hemeek, Israel), and
[3H]thymidine was from NEN Life Science Products.
L-[4,5-3H]Leucine for metabolic labeling of
cells was from Moravek Biochemicals Inc. (Brea, CA), and SPA-polyvinyl
toluene beads were from Amersham Pharmacia Biotech.
Thermal Denaturations--
The thermal denaturations were
carried out using a HP 8453 UV diode-array spectrophotometer with a
heating cell (Hewlett-Packard, Waldbronn, Germany). The spectrum was
monitored between 190 and 1100 nm. Before measurement the cuvette was
cleansed with 6 M guanidine-HCl and Millipore water. SAg
solution was added to the cuvette and diluted with 20 mM
phosphate buffer to give a final SAg concentration of 0.1 mg/ml. The
temperature was raised in steps of 0.5 °C, and at every temperature
the sample solution was left to equilibrate before the absorbance
measurement. The typical temperature interval was 40-75 °C. The
denaturation was visualized by plotting the absorbance difference
A286:A264 (18), and the
denaturation temperatures were defined as the EC50 value.
Expression and Purification of SEA/E Chimeras--
The different
superantigens were expressed constitutively in the
Escherichia coli strain UL 635 (xyl-7,
ara-14, T4R,
ompT) using a vector
(10, 19) with a staphylococci protein A promoter, a signal peptide, and
a kanamycin resistance gene. In the Fab-SAg vector (5, 6), expression
was controlled by a lacUV5 promoter.
The SAgs (Table I) were expressed using either shaker flasks or
fermenters (Belach Bioteknik, Sweden), whereas the C215Fab-SAgs (Table
I) were produced in fermenters. When using shaker flasks, bacteria
containing the respective production plasmid (Table I) were cultivated
for approximately 18 h in 500 ml of 2× YT medium containing 25 µg/ml kanamycin and 12 µg/ml isopropyl
-D-thiogalactoside at 25 °C. The cells, containing
the SAgs, were then harvested by centrifugation at 5000 × g for 30 min.
Production of the Fab-SAgs in fermenters was carried out essentially as
described in Ref. 6. A similar procedure was used for the SAg
expression, although no isopropyl
-D-thiogalactoside was
added. The fermentations were discontinued after 45 h. Metabolic activity was interrupted by cooling the cultivation to 15 °C, and 1 mM EDTA was added. SAgs were recovered from the growth
medium after fermenter cultivations and from the periplasm after shaker flask cultivations.
The periplasmic extraction was carried out by resuspending the cell
pellet in 30 ml of 0.3 M Tris-HCl, 1 mM EDTA,
20% sucrose, pH 7.5, and incubating the suspension for 30 min on ice.
After centrifugation for 15 min at 9300 × g the pellet
was resuspended in 30 ml of 5 mM MgCl2. The
cell debris was removed by centrifugation for 15 min at 6300 × g; the supernatant containing the SEA/E chimera was filtered
to remove remaining debris, and 3 ml of 10× PBS (0.14 M
NaCl, 3 mM KCl, 10 mM phosphate buffer, pH 7.4, and 0.05% Tween 20) were added to the SEA/E solution, which was stored
at
20 °C until purification.
The growth medium or periplasmic extract was diluted to approximately 2 millisiemens/cm, adjusted to pH 5.0, and applied on a HiLoad
26/10® SP-Sepharose® column (Amersham
Pharmacia Biotech). The sample was eluted with a linear gradient from
20 mM to 500 mM ammonium acetate, pH 6.0, with
0.02% Tween 80 over 30 min and a flow rate of 5 ml/min. To wash the
column between samples. 30 ml of 1 M NaOH was used.
The SAg-containing fraction was diluted to approximately 2 millisiemens/cm, adjusted to pH 5.0, and applied on a 1-ml Resource-S column. The sample was eluted with an ammonium acetate buffer gradient
from 20 mM to 500 mM, pH 5.0, with 0.02% Tween
80 over 30 min and a flow rate of 1 ml/min. To wash the column between samples, 2 ml of 1 M NaOH was used. The purified SAg was
concentrated to at least 0.5 mg/ml using ultrafiltration (Centriprep
10, Amicon Inc., Beverly, MA).
The Fab-SAgs were purified using protein G affinity chromatography and
ion-exchange chromatography (6). Typical yields for the SAg chimeras
were 5 mg/l in shaker flasks and 50 mg/l or more in fermenters. The
yield for the Fab-SAgs in fermenters was typically 50-400 mg/l.
Analytical Procedures--
SDS-polyacrylamide gel
electrophoresis was carried out using precast 10-15% polyacrylamide
gradient gels in the Phast system (Amersham Pharmacia Biotech) and
isoelectric focusing with gels ranging from pH 3 to 9. For staining,
Coomassie Blue was used. The purity of the samples was visually
estimated from the SDS-polyacrylamide gel electrophoresis. The protein
concentration of the product solutions was determined with a
UV-spectrophotometer (Hewlett-Packard) at 280 nm. Mass spectrometry was
carried out on a Lasermat 2000 laser desorption/ionization mass
spectrometer (Finnigan Mat ltd, Hemel Hempstead, United Kingdom) with a
matrix consisting of 10 mg/ml sinapinic acid (20) in 30% acetonitrile
with 0.1% trifluoroacetic acid.
CD Measurements--
Both the far UV and near UV CD spectra were
recorded in a 20 mM NaH2PO4 buffer,
pH 6.0, using a Jasco J720 (Japan Spectroscopic Co. Ltd., Hachioji
City, Japan). The path length of the cuvettes used for far and near UV
measurements were 0.1 and 1.0 cm, respectively. The concentration of
the protein solutions used for near UV CD was approximately 0.8 mg/ml
and for far UV CD it was approximately 0.2 mg/ml (21). Corrections were
made in the CD spectra for concentration differences between samples.
Enzyme-linked Immunosorbent Assay Analysis of
C215Fab-SAgs--
Flat bottomed high binding EIA/RIA 96-well plates
(Corning Costar Co., Cambridge, MA) were coated overnight at 4 °C
using 100 µl of 1 µg/ml goat anti-mouse
-chain in 50 mM NaHCO3, pH 9.6. Residual binding sites were
blocked using 3% fat-free dry milk in PBS-Tween, 200 µl/well for
1 h. To each well 100 µl of the respective C215Fab-SAg solution,
0.5 µg/ml in PBS-Tween, was added and incubated for 1 h. As a
negative control, 100 µl of 0.5 µg/ml C215Fab was used. The final
steps were carried out using either human or rabbit antibodies. Using
human antibodies, 100 µl of purified IgG pool at different
concentrations in 3% fat free dry milk in PBS-Tween was added to the
wells and incubated for 2 h, and 100 µl of 1.66 µg/ml
horseradish peroxidase-labeled goat anti human IgG (
-specific) were
added and incubated for 1 h. Alternatively horseradish
peroxidase-labeled rabbit anti-SEA at different concentrations, diluted
in blocking solution, was added and incubated for 2 h. The plates
were developed with the Sigma FastTM OPD peroxidase substrate tablet as
recommended by the supplier. Between each step of the assay the wells
were washed four times with PBS-Tween.
T-Cell Proliferation--
The growth medium used was RPMI 1640 with 10% fetal calf serum, 50 µM 2-mercaptoethanol, and
0.1 mg/ml gentamycin sulfate. Spleen cells from C57B1/6 mice were
obtained in house as a suspension in growth medium. The cells, 2 × 105/well as determined by counting in Bürker
chambers using trypan blue viability staining, were incubated in
96-well flat bottomed plates (Nalgene Nunc International, Denmark). The
SAgs used were analyzed in triplets in the concentration interval
0.001-100 pM. After incubation for 3-4 days the cells
were pulsed with 10 µl of [3H]thymidine (0.05 mCi), and
the DNA of the cells was harvested after 4 h with a Micro Cell
Harvester (SKATRON, Dølasletta, Norway). The radioactivity of the
sample was measured with a 1205 Betaplate Liquid Scintillation Counter
(Wallac Sverige AB, Sollentuna, Sweden).
Scintillation Proximity-based Binding Assay--
Chinese hamster
ovary cells transfected with human CD80 and HLA-DR4 were cultured in
RPMI 1640, supplemented with 10% (v/v) fetal bovine serum, 0.1 mg/ml
gentamycin sulfate, and 1 mM L-methionine sulfoximine.
CHO-CD80-DR4 cells, resuspended to a density of 5 × 106 cells/ml in L-leucine-deficient
(Leu
) medium (L-leucine-free RPMI 1640 medium
supplemented with 2 mg/ml D-glucose, 0.24 mg/ml
L-arginine, 0.035 mg/ml iso-inositol, 0.015 mg/ml
L-methionine, 0.596 mg/ml disodium cysteine, 0.01 mg/ml
L-leucine, 2% (v/v) fetal bovine serum, 0.1 mg/ml
gentamycin sulfate, and 1 mM L-methionine
sulfoximine), were labeled overnight at 37 °C in a CO2
incubator with 0.2 mCi of
L-[4,5-3H]leucine/106 cells. The
next day, [3H]CHO-CD80-DR4 cells were resuspended to a
density of 3 × 105 cells/ml in assay buffer (Hank's
balanced salt solution without phenol red supplemented with 25 mM HEPES, pH 6.8, and 1% (w/v) bovine serum albumin).
The affinity was estimated by calculating half-maximal binding
(Bmax1/2) from the saturation curve. The
C215Fab moiety was used to attach the C215Fab-SEs to the SPA beads
coated with anti-mouse antibodies. Fifty microliters of C215Fab-SE (at
different concentrations) and 50 µl of anti-mouse SPA-polyvinyl
toluene beads (40 mg/ml in assay buffer without bovine serum albumin) were mixed for 1 min in a microtiter plate (OptiPlate, Packard, Greve,
Denmark), covered with a plastic film, and incubated for 30 min to
2 h at 4 °C (depending on the time needed for the preparation of cells). The 3H-labeled cells were added to the
microtiter plate with preincubated C215Fab-SE-SPA beads at a density of
1.5 × 104 cells/50 µl/well. The plate was sealed by
a plastic film, mixed for 1 min on an orbital shaker platform, and
incubated in the dark for 8 h at room temperature. The
radioactivity in each well was measured during 3 min/well using a
-top counter (Packard). As a negative control, C215Fab was used.
 |
RESULTS |
Denaturations of SEA and SEE--
To investigate the stability of
SEA and SEE and understand how it depends on variables such as pH, salt
concentration, and various additives, thermal denaturations were
carried out using a UV spectrophotometer with a heating cell and a
diode array detector. The sample consisted of 0.1 mg/ml SAg dissolved
in 20 mM phosphate buffer of varying pH. At denaturation
the UV absorbance spectra are changed, because buried residues become
exposed. The denaturation was monitored by measuring the difference in
absorbance at 286 and 264 nm, because drastic changes in the absorbance
difference of these two wavelengths occur upon denaturation (18). After denaturation, the SAgs usually precipitated.
The melting points for SEE were generally 5-15 °C higher compared
with SEA. Notably, a biphasic denaturation was observed for SEE between
pH 5.0 and pH 6.5, but at a higher pH the denaturation was monophasic
(Fig. 1). A possible biphasic
denaturation was observed for SEA at pH 5.0. At pH 4.0-5.0 for SEA and
4.0 for SEE, the melting was less distinct suggesting unfolding in a
more complex way. At pH 4.0, both SEA and SEE remained soluble after denaturation while precipitating at the other pHs.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Thermal denaturations of SEA and SEE.
Thermal denaturation curves for SEA (A) and SEE
(B) at pH 5.0-7.0 in the presence of 0.1 mM
Zn2+ ( ) or 1 mM EDTA ( ). Biphasic
denaturations were observed for SEE at pH 5.0 and 6.0 and possibly for
SEA at pH 5.0. The differences in melting points were calculated at
A286:A264 = 0 and are
shown under the respective curves. Zn2+ stabilized the
structures, especially at pH 6.0 and 7.0.
|
|
Denaturations were also carried out with SEA and SEE at pH 4.0-9.0
with the addition of 150 mM NaCl, which substantially
reduced the stability of both SEA and SEE at lower pH by approximately 6 °C, while increasing the thermal stability of SEE at higher pH
with 2-5 °C (data not shown).
To see whether SEE could obtain its original structure from the
partially unfolded state, the temperature gradient was stopped there,
and the sample slowly cooled. However, during this procedure most
material precipitated.
Denaturations of SEA and SEE in guanidine-HCl monitored by far and near
UV CD measurements showed that the tertiary structure unfolds with
midpoints at 1.52 M for SEA and 1.96 M for SEE
(Fig. 2). The secondary structure for SEA
and SEE is lost at 5.10 and 4.14 M, respectively (Fig. 2).
Thus, at pH 6.0 the tertiary structure of SEE is more resistant than
SEA to chemical denaturants, whereas the opposite is true for the
secondary structure.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 2.
Guanidine denaturations of SEA and SEE.
Denaturation of SEA ( ) and SEE ( ) using guanidine followed by CD
at 280 nm (left) and 220 nm (right). Background
signal subtracted.
|
|
In conclusion SEE has a substantially more stable structure than SEA,
and the melting points differ up to 15 °C. At a lower pH the
denaturation of SEA and SEE was less distinct.
Zn2+ Dependence of the Thermal Stability of SEA and
SEE--
To investigate the importance of Zn2+ binding for
thermal stability of SEA and SEE, denaturations were made with buffers
containing 1 mM EDTA to bind Zn2+ ions or
buffers containing 0.1 mM ZnCl2 to saturate the
SAgs with Zn2+. Compared with conditions with no
Zn2+, accomplished by the addition of 1 mM
EDTA, the increase in melting points for SEA with Zn2+
addition was up to 6 °C (Fig. 1). The stabilizing effect of
Zn2+ for SEA was larger at pH 6.0 compared with pH 7.0, but
for SEE (Fig. 1) it was almost independent of pH at pH 5.0, 6.0, and
7.0. The melting points of SEA with the addition of 0, 0.01, and 0.1 mM ZnCl2 increased almost linearly from 59.5 to
61.4 °C but no detectable increase in melting point occurred with
the addition of 1.0 mM ZnCl2 compared with 0.1 mM (data not shown) indicating Zn2+ saturation
of the SAgs at 0.1 m ZnCl2. In contrast 0.1 mM MgCl2 or 0.1 mM
CaCl2 at pH 6.0 stabilized neither the SEA nor the SEE structure (data not shown).
With the Zn2+ addition, SEE exhibited a biphasic
denaturation at pH 5.0 and 6.0, as did SEA at pH 5.0 (Fig. 1).
Interestingly, the denaturation curve of SEA at pH 5.0 was much less
distinct than at pH 6.0 and 7.0, and no precipitate was formed. Unlike SEA, the EDTA-treated SEE showed a substantially less distinct denaturation behavior at pH 7.0 (Fig. 1).
Denaturations were also made on the mutants SEAD227A,
SEAD227A, F47A, SEAH187A, SEED227A,
SEE/A-aD227A, and des(1-5)SEA (Fig. 3, Table
I). The residues Asp-227 and His-187 (10)
are essential for coordination of Zn2+ in the MHC class II
-chain binding site. The residue Phe-47 is located in the MHC class
II
-chain binding site, which is unlikely to be metal
ion-dependent. Similarly Ser1 may be involved in the
Zn2+ coordination (22) according to one crystal
structure.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 3.
Thermal denaturations of SAg mutants.
Melting points ( °C) for wild type SAgs ( ) and the mutants
SEAD227A ( ), SEAH187A( ), SEAF47A,
D227A( ), SEED227A( ), SEE/A-aD227A
( ), and des(1-5)SEA ( ). The melting temperatures for the
variants with replacements in the MHC class II binding sites (Table I)
were generally lower than those for wild type SAgs, although the
difference was larger at pH 7.0 compared with pH 6.0.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Summary of experimental data for the SAgs
SEE/A-a, -f, -h, and -ah are SEE with the regions a,
f, a and a + h
(Fig. 5), respectively, from SEA, whereas SEA/E-bdeg is SEA with the
regions b + d + e + g (Fig. 5) from SEE. In the molecular mass column the
theoretical masses determined from the amino acid sequence (Fig. 5) are
displayed. The EC50 values in the T-cell proliferation assay
are displayed as related to the EC50 values for SEA. The
thermal denaturations were carried out in buffers containing 0.1 mM ZnCl2. When calculating the charge difference
(dCharge) between the SAgs the amino acids Lys and Arg were regarded as
positive, whereas Glu and Asp were regarded as negative. The other
amino acids were regarded as neutral. n/a, not analyzed.
|
|
The replacement of the Zn2+ binding residues strongly
affected the thermal stability of the SAgs. The melting point of
SEAD227A was 1.8 °C lower than SEA at pH 6.0 and
6.3 °C at pH 7.0 (Fig. 3). For SEAH187A the melting
points at pH 6.0 and 7.0 were lowered 0.5 and 3.9 °C, respectively.
The stability decrease for SEED227A relative to SEE was
2 °C at pH 6.0 and 4 °C at pH 7.0 (Fig. 3). SEE/A-aD227A had melting points 5.5 and 6 °C lower than
SEE/A-a at pH 6.0 and 7.0, respectively (Fig. 3). SEAD227A,
F47A was slightly more stable than SEAD227A but
still less stable than SEA (Fig. 3). Des(1-5)SEA denaturated at
approximately 56 °C at pH 7.0, a thermal stability decrease relative
to SEA of 5.5 °C (Fig. 3). Interestingly the D227A/H187A mutants
with substantially lower affinity than SEAwt for Zn2+ (10)
were also to some extent stabilized by the addition of Zn2+
(data not shown).
In conclusion, the addition of Zn2+ to SEA and SEE
increased the stability compared with Zn2+-free conditions.
The substitution H187A in SEA and D227A in SEA, SEE, and SEE/A-a had a
clear destabilizing effect, indicating that these residues are very
important for the stability of the SAgs. The destabilizing effect was
more pronounced at pH 7.0 than at pH 6.0. The substitution F47A in SEA
stabilized the structure at both pH 6.0 and 7.0. Because of the
substantial influence of Zn2+ on the stability of the SAgs,
all denaturations were henceforth carried out in the presence of 0.1 mM ZnCl2.
Characterization of the SEA/E Chimeras--
SEA and SEE have a
sequence identity of approximately 80%. The main differences are found
in eight different regions, four close to the two MHC class II binding
sites and four in the vicinity of the TCR binding site (16) (Fig.
4). The chimeras SEE/A-a, SEE/A-f,
SEE/A-h, SEE/A-ah, and SEA/E-bdeg (Table I) were prepared to study the
impact of replacement of these regions. Region f in SEE
contains two unique histidine residues, which might influence the
biphasic denaturation behavior of SEE (Fig. 1), and regions a and h are in the vicinity of region
f. In the chimera SEA/E-bdeg the influence of the whole TCR
binding site on the denaturation behavior of SEA and SEE was
investigated.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
The amino acid sequences for SEA and
SEE. The regions A, C, F, and
H are close to the proposed T-cell receptor binding site,
whereas the regions B, D, E, and
G are close to the two MHC class II binding sites.
|
|
The purification of the SAgs was carried out in two ion-exchange
chromatography steps, whereas the Fab-SAgs were recovered using a
protein G affinity chromatography step followed by ion-exchange chromatography (6). The purity of the products was determined to be at
least 90% (data not shown) using SDS-polyacrylamide gel electrophoresis and isoelectric focusing. The identities were confirmed
using matrix-assisted laser desorption/ionization-mass spectroscopy
(Table I).
Notably, the isoelectric points differed substantially between the
chimeras and the wild type SAgs (Table I). SEE/A-ah and SEE/A-h, with a
positive charge difference of one or two relative to SEE, had
isoelectric points at 8.0 or 8.2 compared with 7.4 for SEE, which
suggests some conformational differences between the SAgs. Therefore CD
spectra were acquired for SEA, SEE, SEE/E-f, and SEE/A-a. The far-UV CD
spectra, 200-250 nm, derived primarily from the secondary structure of
the proteins (23), were indistinguishable for all SAgs (Fig.
5). The near UV CD spectra, primarily
arising from the tertiary structure in the vicinity of the aromatic
amino acid residues Tyr and Trp (23), showed larger differences (Fig. 5) indicating subtle conformational differences in the tertiary structure between the SAgs. Further evidence for structural differences was obtained by enzyme-linked immunosorbent assay analysis of SEA, SEE,
and the chimeras, which showed that the binding of antibodies to SEE
was substantially less than for SEA (data not shown). Interestingly the
chimera SEE/A-f, although being sequentially more SEA-like than SEE,
produced a lower response against rabbit anti-SEA than SEE. Similarly,
SEE/A-a produced a lower or equal response than SEE against a human IgG
pool.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 5.
Far and near UV CD spectra of the SAgs.
Far (A) and near (B) UV CD spectra of SEA ( ),
SEE ( ), SEE/A-a (X), and SEE/A-f ( ). The spectra are similar in
the far UV region, whereas they differ markedly in the near UV region.
This indicates that the SAgs have a similar secondary structure,
although the tertiary structure differs.
|
|
To study whether regions that contain the TCR binding site influence
the unfolding properties of SEA and SEE, thermal denaturations of
SEE/A-a, SEE/A-f, SEE/A-h, SEE/A-ah, and SEA/E-bdeg were studied at pH
6.0-7.0 (Table I). The regions a, f, and h contain putative TCR-binding residues (16). SEA/E-bdeg has
the two MHC class II binding regions from SEE and the TCR binding
region from SEA. To get an excess of Zn2+, avoiding
differences in this important parameter, 0.1 mM
ZnCl2 was added. The results of the thermal denaturation of
these molecules are shown in Fig. 6 and
Table I.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
Thermal denaturations of the SEA/E
chimeras. Thermal denaturation curves at pH 6.0 ( ) and 7.0 ( -) for the chimeras SEE/A-a, -f, -h, -ah, and SEA/E-bdeg.
SEA/E-bdeg exhibits a biphasic denaturation at pH 6.0 and SEE/A-h at pH
7.0, but the denaturation process of SEE/A-h at pH 6.0 seems to be more
complex.
|
|
The melting points for the chimeras were all lower than for SEE, with
the exception of SEE/A-a at pH 6.0 and 7.0 and SEE/A-h at pH 6.0 but
substantially higher compared with SEA (Table I). Notably SEE/A-a and
SEE/A-h, at pH 6.0, had higher melting points than SEE (Table I),
whereas SEE/A-ah had a lower melting point, indicating that a
combination of these two stabilizing regions reversed this effect.
Interestingly the chimeras where region h had been replaced,
SEE/A-h and SEE/A-ah, were significantly stabilized by the lower pH
contrasting the other chimeras.
The melting points of SEE/A-a and SEE/A-f increased from pH 6.0 to 7.0 with approximately 1 °C for SEE/A-a and 2 °C for SEE/A-f (Table
I). For the chimeras SEE/A-h and SEE/A-ah the melting points decreased
from pH 6.0 to 7.0 with approximately 11 °C for SEE/A-h and 3 °C
for SEE/A-ah. The melting point for SEA/E-bdeg was approximately
68-69 °C at both pH 6.0 and 7.0. The differences in melting points
between pH 7.0 and 6.0 could be caused by residues, which are important
for the structural stability of the protein in the present
conformation, becoming protonated between pH 7.0 and 6.0 and thereby
acquiring a charge, which might change the stability of the structure.
Biphasic denaturations were observed for SEA/E-bdeg at pH 6.0 and by
SEE/A-h at pH 7.0. The denaturation behavior of SEE/A-h at pH 6.0 seems
to be more complex with the SAg not precipitating at denaturation (Fig.
6). SEE/A-a, -f, and -ah showed no biphasic denaturation behavior.
Interestingly, SEA/E-bdeg composed of SEA with the two MHC class II
binding sites from SEE was substantially more stable than SEA,
indicating that several different regions contribute to the greater
stability of SEE. Of the chimeras, SEE/A-h and SEA/E-bdeg showed
biphasic denaturations.
In conclusion, most likely there are conformational differences between
the SEA/E chimeras indicated by isoelectric focusing and near UV CD
spectra as well as the low antibody binding properties of SEE/A-a and
SEE/A-f. The thermal stability of all the chimeras was higher than for
SEA with the highest melting points obtained for SEE/A-a and SEE/A-h,
but a combination of these two chimeras, SEE/A-ah, was substantially
less stable.
Binding of SE Fusion Proteins to MHC Class II-expressing
Cells--
The interaction between C215Fab-SEs and human MHC class II
(HLA-DR4) presented on cells was studied using a binding assay based on
the SPA technology. To detect the binding of SEs to HLA-DR4, the
C215Fab-SEs was attached to SPA beads coated with anti-mouse Ig
antibodies via the Fab moiety, whereas the cells expressing HLA-DR4
were labeled by the incorporation of [3H]leucine. The
concentration yielding half-maximal binding (Bmax
1/2) was used as an estimate of the binding affinity.
Bmax 1/2 concentrations for the different
C215Fab-SEs analyzed (Fig. 7) were found
to be approximately in the same range (2 × 10
8
M) (data not shown). This indicates a similar affinity for
HLA-DR4, for SEA, SEE, and the chimeras. A striking difference,
however, in the saturation amplitude was noticed for the C215Fab-SEs
(Fig. 7). The highest amplitude was seen for C215Fab-SEE/A-h, which was
about twice the height of the cluster obtained for the SEA, SEE,
SEE/A-h, and SEE/A-ah C215Fab fusion proteins. C215Fab-SEE/A-f and
C215Fab-SEA/-bdeg formed an additional cluster of C215Fab fusion
proteins, with an amplitude half of that obtained for the C215Fab-SEA
cluster. These results indicate that the replacement of region
a, alone or together with region h, does not
affect the number of binding sites, whereas replacement of region
h doubles the number of binding sites compared with that for
the SEA cluster. In the same way, a replacement of region f
or region bdeg results in a
50% decrease in the number of
binding sites compared with the SEA cluster. These experiments were
performed at pH 6.8.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 7.
MHC class II binding curves for the
Fab-SAgs. Representative saturation curves for binding of SEA
( ), SEE ( ), SEE/A-a (X), SEE/A-f ( ), SEE/A-h ( ), SEE/A-ah
( ), and SEA/E-bdeg ( ) all fused with C215Fab, to
3H-Leu-labeled Chinese hamster ovary-CD80-DR4 cells
(1.5 × 104 cells/well) in a SPA assay. The binding
curves shown here are from one of three series of experiments. For
further details see "Experimental Procedures."
|
|
Biological Assays--
To investigate if structural or stability
differences of SEA and SEE could be correlated to murine T-cell
proliferative capacity a T-cell proliferation assay was carried out for
SEA, SEE, and the chimeras at concentrations varying from 0.001 to 100 pM using spleen cells from C57B1/6 mice. The analysis of
the proliferative activity was carried out after 3 and 4 days by
pulsing the cells with [3H]thymidine, harvesting the DNA
of the cells after 4 h of incubation, and measuring the radioactivity.
SEE/A-a, SEE/A-h, SEE/A-ah, and SEA/E-bdeg were equipotent to SEE,
whereas SEE/A-f and SEA showed an approximately three times lower
proliferating activity (Table I) as determined by EC50 values. Using human T-cells (16), SEE/A-f was less potent, whereas the
proliferating activity for SEA was similar to the other SAgs.
 |
DISCUSSION |
Several studies have speculated in the importance of
conformational changes for superantigen function (24, 25). In this study we have investigated the structural properties of several SEA and
SEE variants. The results clearly support the previous hypotheses.
Although the amino acid sequences of SEA and SEE are very similar,
there are differences in biological function. The V
-specificities
for SEA and SEE differ (2, 17) as do their affinities to different MHC
class II alleles (9), and SEA may also have a different affinity for
the TCR than SEE (16). Interestingly, in many cases chimerical
molecules of SEA and SEE acquire properties that are unique and not the
predicted combinations between SEA and SEE (Figs. 5-7). Replacing
Phe-47 with Ala reduces the number of V
s that can be activated (25).
This could be caused by the inability of this, more structurally stable
variant (Fig. 3) to undergo a necessary conformational change.
These findings can be explained by the subtle differences in the
tertiary structure between the SAgs (Fig. 5). The MHC class II binding
regions in SEE are mostly responsible for this stabilization, whereas
the TCR binding sites seem more flexible. Notably, the tertiary
structure of SEE was more stable than that of SEA, although the
opposite was true concerning the secondary structure (Fig. 2). Thus, it
is likely that some side chains primarily contribute to tertiary
interactions, e.g. by burying hydrophobic surface area in
the core of the protein whereas others mainly stabilize secondary
structure, and that SEE and SEA differ in both types of side chains.
Interestingly, both guanidine-induced and thermal (data not shown)
denaturations of SEA and SEE monitored using CD showed that the
tertiary structure was unfolded before the secondary structure.
Tertiary structure is generally lost before secondary structure when
the two levels of structure do not disappear concomitantly, as in
e.g. the molten globule, and indicates that the transition
observed when performing UV monitored thermal denaturations is mainly
an unfolding of tertiary structure.
The regions a, f, and h are important
for the conformation of SEE, as suggested by isoelectric focusing, CD,
antibody recognition, and MHC class II binding assays (Fig. 5 and 7,
Table I). We therefore propose that the TCR binding site in SEs can
adopt different conformations that are controlled by subtle differences
in this region. This is supported by observed differences in
V
-specificity between SEA and SEE (2, 17) and the SEA/E chimeras
(16). Thus, several of the residues in the TCR binding site have
important functions in controlling the structure, such as the ability
for structural modification upon receptor binding and affinity and
specificity. Interestingly, these regions may also influence the
stochiometry in binding to MHC class II (Fig. 7), perhaps by having
structures that facilitate or hinder binding via the low affinity
binding sites.
At certain pH values a biphasic denaturation occurs indicating a
partial unfolding in the SAgs. SEE/A-f and SEE/A-ah showed no biphasic
denaturation, whereas SEE/A-a, SEE/A-h, and SEA/E-bdeg did. Because the
biphasic melting is only observed at pH 5.0 and 6.0 but not at pH 7.0, it was hypothesized that it involved His residues getting ionized.
Notably SEE/A-f, with two His residues replaced, lacks a biphasic
melting suggesting a role for His-161 or His-164 in this local
destabilization. Thus, at least one of these two His residues may form
parts of the flexible elements that control the structure of the TCR
binding site. This hypothesis is further supported by the similar
T-cell-proliferating properties of SEE/A-f and SEA. However, there is a
biphasic denaturation with a larger absorbance difference in
SEA/E-bdeg, which also lacks the two His-161 and His-164, indicating
more complete unfolding or that another region is denatured. Therefore,
biphasic melting occurs with certain combinations of residues that
destabilize the structure.
Zn2+ is important for the MHC class II affinity of both SEA
and SEE (9), as well as the reduction in monokine release triggered by
SEA and SEE, but Zn2+ does not influence the V
-specific
T-cell stimulation (26). Loss of Zn2+ coordination
significantly lowers the potency of SEA (27). From the data presented
here, it is clear that Zn2+ also stabilizes the structures
of SEA and SEE, especially at physiological pH. Coordination of metal
ions often leads to stabilized structures and can increase melting
points with approximately 10 °C including both functional
Mg2+ (28) and engineered Zn2+ binding sites
(29, 30). The importance of the Zn2+ binding region for the
thermal stability of SEA and SEE was further shown by the dramatic
decrease in melting point at pH 7.0 for the SEA Zn2+
binding site mutants, such as SEAD227A. Although having a
reduced Zn2+ binding, the variants were all stabilized by
the addition of a high concentration of Zn2+ indicating
that they bind Zn2+ through the known site but with a
significantly reduced affinity. Alternatively, an unknown
Zn2+ binding site could exist (24). Because
SEAD227A was less stable than EDTA-treated SEA, this
replacement destabilizes or affects the structure of this MHC class II
binding site. This suggests that the very low affinity of this variant
for MHC class II is caused by two independent mechanisms, removal of
the coordinated Zn2+ ion and structural disturbance. In
contrast SEAH187A is more stable than SEAD227A
and has a much higher MHC class II affinity and activity (10, 11),
indicating that here the structure is less affected. In the SEA crystal
structure Asp-227 is less exposed compared with His-187 (22).
In conclusion residues in the Zn2+ binding site are very
important for the stability and potency of SEA and SEE, whereas
residues in the TCR binding site have a substantial influence on the
molecular conformation, which may control specificity and function. Our findings will further guide us to understand how bacterial
superantigens have evolved and how their potent T-cell stimulatory
capacity is maintained on the molecular level. However, these finding
will also help us to design superantigens that could have clinical benefits, such as cancer therapy (5, 31).
 |
ACKNOWLEDGEMENT |
We thank Helen Nilsson, Eva Erlandsson, and
Marcela Gonzalez for assistance with molecular biology procedures. We
also thank Annelie Sjöberg and Ulla Larsson-Lorek for support
with the cultivations and Christine Valfridsson for help with the
T-cell proliferation assay. Finally, we thank Mats Åkesson for the
assistance with the matrix-assisted laser desorption/ionization mass
spectrometry analysis and Ulf Niss for purification of the
Fab-SAgs.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.: 46 46-191154; Fax: 46 46-191134; E-mail:
goran.forsberg@activebiotech.com.
 |
ABBREVIATIONS |
The abbreviations used are:
SAg, superantigen;
CD, circular dichroism;
IgG, immunoglobulin G;
MHC class II, major
histocompatibility complex class II;
SE, staphylococcal enterotoxin;
SEA, staphylococcal enterotoxin A;
SEE, staphylococcal enterotoxin E;
PBS, phosphate-buffered saline;
TCR, T-cell receptor;
SPA, scintillation proximity assay.
 |
REFERENCES |
| 1.
|
Johnson, H. M.,
Russell, J. K.,
and Pontzer, C. H.
(1992)
Sci. Am.
266,
42-48
|
| 2.
|
Marrack, P.,
and Kappler, J.
(1990)
Science
248,
705-711[Abstract/Free Full Text]
|
| 3.
|
Choi, Y.,
Herman, A.,
DiGiusto, D.,
Wade, T.,
Marrack, P.,
and Kappler, J.
(1990)
Nature
346,
471-473[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
White, J.,
Herman, A.,
Pullen, A. M.,
Kubo, R.,
Kappler, J. W.,
and Marrack, P.
(1989)
Cell
56,
27-35[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Dohlsten, M.,
Abrahmsén, L.,
Björk, P.,
Lando, P. A.,
Hedlund, G.,
Forsberg, G.,
Brodin, T.,
Gascoigne, N. R. J.,
Förberg, C.,
Lind, P.,
and Kalland, T.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8945-8949[Abstract/Free Full Text]
|
| 6.
|
Forsberg, G.,
Forsgren, M.,
Jaki, M.,
Norin, M.,
Sterky, C.,
Enhörning, Å.,
Larsson, K.,
Ericsson, M.,
and Björk, P.
(1997)
J. Biol. Chem.
272,
12430-12436[Abstract/Free Full Text]
|
| 7.
|
Munson, S. H.,
Tremaine, M. T.,
Betley, M. J.,
and Welch, R. A.
(1998)
Infect. Immun.
66,
3337-3348[Abstract/Free Full Text]
|
| 8.
|
Zhang, S.,
Iandolo, J. J.,
and Stewart, G. C.
(1998)
FEMS Microbiol. Lett.
168,
227-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Fraser, J. D.,
Urban, R. G.,
Strominger, J. L.,
and Robinson, H.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
5507-5511[Abstract/Free Full Text]
|
| 10.
|
Abrahmsén, L.,
Dohlsten, M.,
Segrén, S.,
Björk, P.,
Jonsson, E.,
and Kalland, T.
(1995)
EMBO J.
14,
2978-2986[Medline]
[Order article via Infotrieve]
|
| 11.
|
Hudson, K. R.,
Tiedemann, R. E.,
Urban, R. G.,
Lowe, S. C.,
Strominger, J. L.,
and Fraser, J. D.
(1995)
J. Exp. Med.
182,
711-720[Abstract/Free Full Text]
|
| 12.
|
Mourad, W.,
Mehindate, K.,
Schall, T. J.,
and McColl, S. R.
(1992)
J. Exp. Med.
175,
613-616[Abstract/Free Full Text]
|
| 13.
|
Mehindate, K.,
Thibodeau, J.,
Dohlsten, M.,
Kalland, T.,
Sékaly, R-P.,
and Mourad, W.
(1995)
J. Exp. Med.
182,
1573-1577[Abstract/Free Full Text]
|
| 14.
|
Sundström, M.,
Hallén, D.,
Svensson, A.,
Schad, E.,
Dohlsten, M.,
and Abrahmsén, L.
(1996)
J. Biol. Chem.
271,
32212-32216[Abstract/Free Full Text]
|
| 15.
|
Karp, D. R.,
and Long, E. O.
(1992)
J. Exp. Med.
175,
415-424[Abstract/Free Full Text]
|
| 16.
|
Antonsson, P.,
Wingren, A. G.,
Hansson, J.,
Kalland, T.,
Varga, M.,
and Dohlsten, M.
(1997)
J. Immunol.
158,
4245-4251[Abstract]
|
| 17.
|
Irwin, M. J.,
Hudson, K. R.,
Fraser, J. D.,
and Gascoigne, N. R.
(1992)
Nature
359,
841-843[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Pace, C. N.,
Shirley, B. A.,
and Thomson, J. A.
(1989)
in
Protein Structure: A Practical Approach
(Creighton, T. E., ed)
, pp. 311-313, IRL Press, Oxford
|
| 19.
|
Nilsson, B.,
Forsberg, G.,
and Hartmanis, M.
(1990)
Methods Enzymol.
198,
3-16
|
| 20.
|
Butler, J. M.,
Jiang-Baucom, P.,
Huang, M.,
Belgrader, P.,
and Girard, J.
(1996)
Anal. Chem.
68,
3283-3287[Medline]
[Order article via Infotrieve]
|
| 21.
|
Kelly, S. M.,
and Price, N. C.
(1997)
Biochim. Biophys. Acta
1338,
161-185[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Schad, H.,
Zaitseva, I.,
Zaitsev, V. N.,
Dohlsten, M.,
Kalland, T.,
Schlievert, P. M.,
Ohlendorf, D. H.,
and Svensson, L. A.
(1995)
EMBO J.
14,
3292-3301[Medline]
[Order article via Infotrieve]
|
| 23.
|
Fasman, G. D.
(ed)
(1996)
Circular Dichroism and the Conformational Analysis of Biomolecules
, Plenum Publishing Corp., New York
|
| 24.
|
Schad, E. M.,
Papageorgiou, A. C.,
Svensson, L. A.,
and Acharaya, K. R.
(1997)
J. Mol. Biol.
269,
270-280[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Lando, P. A.,
Olsson, C.,
Kalland, T.,
Newton, D.,
Kotd, M.,
and Dohlsten, M.
(1996)
J. Immunol.
157,
2857-2863[Abstract]
|
| 26.
|
Driessen, C.,
Hirv, K.,
Kirchner, H.,
and Rink, L.
(1995)
Immunology
84,
272-277[Medline]
[Order article via Infotrieve]
|
| 27.
|
Holzer, U.,
Orlikowsky, T.,
Zehrer, C.,
Bethge, W.,
Dohlsten, M.,
Kalland, T.,
Niethammer, D.,
and Dannecker, G. E.
(1997)
Immunology
90,
74-80[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Kanaya, S.,
Oobatake, M.,
and Liu, Y.
(1996)
J. Biol. Chem.
271,
32729-32736[Abstract/Free Full Text]
|
| 29.
|
Burlacu-Miron, S.,
Perrier, V.,
Gilles, A-M.,
Pistotnik, E.,
and Craescu, C. T.
(1998)
J. Biol. Chem.
273,
19102-19107[Abstract/Free Full Text]
|
| 30.
|
Perrier, V.,
Burlacu-Miron, S.,
Bourgeois, S.,
Surewicz, W. K.,
and Gilles, A-M.
(1998)
J. Biol. Chem.
273,
19097-19101[Abstract/Free Full Text]
|
| 31.
|
Rosendahl, A.,
Kristensson, K.,
Hansson, J.,
Olsson, L.,
Kalland, T.,
and Dohlsten, M.
(1998)
Int. J. Cancer
76,
274-283[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Sorensen, M. Kussmann, A. Rosen, K. L. Bennett, D. d. G. Thrige, K. Uvebrant, B. Walse, P. Roepstorff, and P. Bjork
Identification of Protein-Protein Interfaces Implicated in CD80-CD28 Costimulatory Signaling
J. Immunol.,
June 1, 2004;
172(11):
6803 - 6809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-A. Langlois, Y. E. Fakhry, and W. Mourad
Zinc-binding Sites in the N Terminus of Mycoplasma arthritidis-derived Mitogen Permit the Dimer Formation Required for High Affinity Binding to HLA-DR and for T Cell Activation
J. Biol. Chem.,
June 13, 2003;
278(25):
22309 - 22315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Swietnicki, A. M. Barnie, B. K. Dyas, and R. G. Ulrich
Zinc Binding and Dimerization of Streptococcus pyogenes Pyrogenic Exotoxin C Are Not Essential for T-cell Stimulation
J. Biol. Chem.,
March 7, 2003;
278(11):
9885 - 9895.
[Abstract]
[Full Text]
[PDF]
|
 |
|